Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7615213 Antibodies against human interleukin-13 and pharmaceutical compositions thereof

Patent 7615213 was granted and assigned to Wyeth on November, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Wyeth
Wyeth
0
Date Filed
June 9, 2005
0
Date of Patent
November 10, 2009
0
Patent Application Number
11149309
0
Patent Citations Received
‌
US Patent 11697683 Anti-IL31 antibodies for veterinary use
0
‌
US Patent 11667706 Methods of purifying recombinant anti-abeta antibodies
0
‌
US Patent 11964016 Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
0
‌
US Patent 12084494 Interleukin-31 monoclonal antibodies for veterinary use
0
‌
US Patent 11912773 Fc variants and methods for their production
0
‌
US Patent 11673946 Methods of treating a companion animal species comprising administering anti-IL31 antibodies
0
‌
US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases
Patent Inventor Names
Nancy L. Wood
0
Samuel J. Goldman
0
Tania Shane
0
Xiang-Yang Tan
0
Geertruida M. Veldman
0
Amy Sze Pui Tam
0
Angela M. Widom
0
Debra D. Donaldson
0
Eric Feyfant
0
Jose W. Saldanha
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7615213
0
Patent Primary Examiner
‌
Ram R. Shukla
0

Find more entities like US Patent 7615213 Antibodies against human interleukin-13 and pharmaceutical compositions thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.